Charles Schwab’s Athenahealth, Inc. ATHN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-248,237
Closed -$32.8M 3228
2018
Q4
$32.8M Sell
248,237
-37,026
-13% -$4.74M 0.03% 655
2018
Q3
$38.1M Buy
285,263
+56,236
+25% +$8.43M 0.03% 675
2018
Q2
$36.4M Buy
229,027
+12,633
+6% +$1.87M 0.03% 663
2018
Q1
$31M Buy
216,394
+17,477
+9% +$2.39M 0.02% 723
2017
Q4
$26.5M Buy
198,917
+14,933
+8% +$1.91M 0.02% 788
2017
Q3
$22.9M Buy
183,984
+13,006
+8% +$1.79M 0.02% 825
2017
Q2
$24M Buy
170,978
+9,960
+6% +$1.24M 0.02% 730
2017
Q1
$18.1M Buy
161,018
+16,256
+11% +$1.89M 0.02% 892
2016
Q4
$15.2M Buy
144,762
+10,622
+8% +$1.14M 0.02% 944
2016
Q3
$16.9M Buy
134,140
+11,482
+9% +$1.46M 0.02% 793
2016
Q2
$16.9M Buy
122,658
+5,999
+5% +$794K 0.02% 733
2016
Q1
$16.2M Buy
116,659
+3,987
+4% +$547K 0.02% 741
2015
Q4
$18.1M Buy
112,672
+7,346
+7% +$1.13M 0.02% 648
2015
Q3
$14M Buy
105,326
+7,162
+7% +$934K 0.02% 750
2015
Q2
$11.2M Buy
98,164
+6,957
+8% +$832K 0.02% 943
2015
Q1
$10.9M Buy
91,207
+10,664
+13% +$1.42M 0.02% 944
2014
Q4
$11.7M Buy
80,543
+6,836
+9% +$858K 0.02% 780
2014
Q3
$9.71M Buy
73,707
+1,489
+2% +$196K 0.02% 861
2014
Q2
$9.04M Sell
72,218
-53,552
-43% -$6.92M 0.02% 921
2014
Q1
$20.2M Buy
125,770
+5,908
+5% +$972K 0.04% 460
2013
Q4
$16.1M Buy
119,862
+7,253
+6% +$932K 0.03% 499
2013
Q3
$12.5M Buy
112,609
+6,130
+6% +$663K 0.03% 535
2013
Q2
$9.05M Buy
+106,479
New +$9.53M 0.02% 625

Charles Schwab's ATHN Position: Q1 2019 in Review

Charles Schwab sold out of Athenahealth, Inc. (ATHN) in Q1 2019, closing a stake of 248,237 shares — an estimated $32.8M sold.

Charles Schwab first reported a position in ATHN in Q2 2013 and held it in 23 quarters. The position peaked at $38.1M in Q3 2018. 0 funds tracked by Wall St. Rank hold ATHN as of Q1 2019.

  • Charles Schwab reported no remaining Athenahealth, Inc. position as of Q1 2019 after selling out during the quarter.
  • Charles Schwab sold 248,237 Athenahealth, Inc. shares in Q1 2019, an estimated $32.8M.
  • Charles Schwab first reported a position in Athenahealth, Inc. in Q2 2013 and held it in 23 quarters.
  • Charles Schwab's Athenahealth, Inc. position peaked at $38.1M in Q3 2018.
  • 0 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q1 2019.

Based on Charles Schwab's 13F filing for Q1 2019, filed 14 May 2019.